Company / PP&E per Share
Aurinia Pharmaceuticals Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.01 / $0.04
FY2021-FY2025
Trend
-21.1%
vs FY2024
Sector context
#150 of 191
Health Care
What the data says
Aurinia Pharmaceuticals Inc.'s pp&e per share of $0.01 is lower than 79% of companies in the Health Care sector (FY2025). PP&E per Share has declined for 5 consecutive years, from $0.06 in FY2020 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -23.2%.
Declined from $0.02 to $0.01 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -19.6%
- 5-Year CAGR
- -23.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 191This company $0.01 Sector average $18.90
▼
-99.9% below sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s pp&e per share has declined for 5 consecutive years.
- In FY2025, pp&e per share decreased 21.1% year-over-year.
- Ranks #150 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -21.1% |
| FY2024 | $0.02 | -19.8% |
| FY2023 | $0.02 | -17.8% |
| FY2022 | $0.03 | -27.1% |
| FY2021 | $0.04 | -29.4% |
| FY2020 | $0.06 | +5499.1% |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026